BioXcel Therapeutics (BTAI) Operating Margin (2022 - 2026)
BioXcel Therapeutics (BTAI) operating margin from Sep 30, 2022 to Mar 31, 2026. The current BioXcel Therapeutics (BTAI) operating margin is -4866.67%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of BioXcel Therapeutics (BTAI)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -7884.38% | +166.17% |
| 2024 | -2962.11% | -76.20% |
| 2023 | -12447.83% | -70.37% |
| 2022 | -42013.16% | N/A |
Comparison BioXcel Therapeutics (BTAI) operating margin with competitors
BioXcel Therapeutics (BTAI) operating margin is -4866.67%.